Amidst a pharma spending spree, Johnson & Johnson $3.4bn acquisition of Auris Health is a move towards turning around its medical devices.

Cigna’s $70bn acquisition of Express Scripts was the biggest deal by volume announced in 2018, but was it the smartest?

This deal will allow the biopharmaceutical giant to diversify its drug portfolio and stay on the cutting edge of experimental therapy.

By Carlos Asorey (Georgetown University) 26/10/2018 | Overview of the deal Acquirer: RCCH HealthCare Partners Target: LifePoint Health...

Overview of the deal Acquirer: Takeda Target: Shire Estimated value: $62 bn Announcement date: 08/05/18 Takeda Advisors: Evercore, JP...

Overview of the deal Acquirer: Bayer Target: Monsanto Estimated value: $66 billion Announcement date: May 2016 Acquirer Advisors: Credit...

Overview of the deal Acquirer: Sanofi SA (Paris: SAN) Target: Bioverativ. (NASDAQ: BIVV) Estimated value: $11.6bn Announcement date: 3/12...

Overview of the deal Initiating firm: Essilor Approached firm: Luxottica Estimated value: $54 Bn (including net debt) Announcement:...

Overview of the deal Acquirer: CVS Health Corporation (NYSE: CVS) Target: Aetna Inc. (NYSE: AET) Estimated value: $69bn ($77bn including...